Veraxa Biotech Holding AG (VRXA) Cash from Operations (2025)
Veraxa Biotech Holding AG (VRXA) posted Cash from Operations of 1251.17 for Q4 2025.
Veraxa Biotech Holding AG (VRXA) Cash from Operations (2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXA) has reported Cash from Operations for 1 consecutive years, with 1251.17 the latest figure, recorded in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,251.17 |
| Dec 31, 2025 | 1,251.17 |